Tempus Ai

This study aims to learn more about small cell lung cancer by analyzing patients' tumor tissue and blood samples. Researchers will collect these samples while patients receive their standard cancer treatments. The goal is to identify biological markers that could help predict tre…

This study aims to build a large collection of blood and tissue samples from 500 cancer patients. Researchers will track specific DNA markers in the blood over time to see how they change with standard treatments. The goal is to learn if these markers can help predict how well a …

This study aims to discover molecular patterns in blood and tissue that might predict how patients with acute myeloid leukemia or follicular lymphoma respond to treatment. Researchers will collect samples from 550 patients during their regular care and track their health outcomes…

This study aims to discover biological markers in the blood and tissue of 500 people with advanced head and neck cancer. Researchers will collect samples during patients' standard treatments to understand what makes the disease progress or respond to therapy. The goal is to gathe…

This study aims to see if a simple blood test can find tiny bits of leftover cancer DNA after treatment. Researchers will track 900 patients with early-stage breast cancer to see if this 'liquid biopsy' can predict if their cancer will come back. The goal is to gather knowledge t…

This study aims to understand how non-small cell lung cancer changes at a molecular level during standard treatment. It will follow 1,200 patients, collecting blood samples over time to see if tiny traces of cancer DNA in the blood can predict if the cancer will come back or how …